Log In
Print
BCIQ
Print
Print this Print this
 

Rebif, interferon beta-1a

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionNew formulation of Rebif recombinant interferon (IFN) beta-1a containing no human- or animal-derived serum
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionImmune modulation
Latest Stage of DevelopmentMarketed
IndicationMultiple sclerosis (MS)
Partner

Pfizer Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today